No Data
Kaisheng New Materials (301069.SZ): The company's controlling Shareholder Huapont Life Sciences intends to issue Exchangeable CSI Enterprise bond Index.
On December 11, Glonghui reported that Kaisheng New Materials (301069.SZ) announced that its controlling shareholder Huapont Life Sciences intends to issue non-publicly exchanged bonds with part of the company's A-shares it directly Holds as the symbol. The proposed issuance period is no more than 3 years, and the proposed fundraising scale is no more than 1 billion yuan. Under the conditions for stock exchange, bondholders can exchange the bonds for the company's A-shares at the agreed exchange price during the exchange period. Huapont Life Sciences will provide guarantees for the issuance of bonds with part of the company's A-shares it Holds and their income. The issuance of the exchangeable bonds has been reviewed and approved by the Board of Directors and still needs to be approved by the Shareholders' Meeting.
Huapont Life Sciences (002004.SZ): Plans to privately issue up to 1 billion yuan of exchangeable CSI Enterprise bonds.
Gelonghui, December 10 - huapont life sciences (002004.SZ) announced that the company will hold the 21st meeting of the 8th board of directors on December 10, 2024, to review and approve relevant proposals including "Proposal on the Company's Compliance with Conditions for Private Placement of Exchangeable Corporate Bonds", "Proposal on the Company's Private Placement Plan for Exchangeable Corporate Bonds", and "Proposal to Authorize the Board of Directors to Handle All Matters Related to this Private Placement of Exchangeable Corporate Bonds". Taking into full consideration the company's global strategy and combining the company's actual situation, the company intends to privately place exchangeable bonds to professional institutional investors.
Huapont Life SciencesLtd (SZSE:002004) Is Posting Promising Earnings But The Good News Doesn't Stop There
Huapont Life Sciences (002004.SZ): has repurchased 0.35% of shares accumulated.
As of October 31, 2024, Huapont Life Sciences (002004.SZ) announced that the company has repurchased a total of 6,959,908 shares of the company through centralized trading, accounting for 0.35% of the company's current total share capital. The highest fill price was 4.65 yuan/share, the lowest fill price was 3.84 yuan/share, and the total amount paid was 29.4993 million yuan (excluding trading fees).
Huabang Health: Report for the third quarter of 2024
Huapont Life Sciences (002004.SZ) released its performance for the first three quarters, with a net income of 0.452 billion yuan, a year-on-year decrease of 10.49%.
huapont life sciences (002004.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue...
Returns At Huapont Life SciencesLtd (SZSE:002004) Appear To Be Weighed Down
